Conceptio
›
Archive
›
NCBI PubMed Central
NCBI PubMed Central
open access
Real-world effectiveness and safety of tralokinumab in moderate-to-severe atopic dermatitis with malignancy, chronic infections, and multimorbidity.
Melgosa Ramos FJ et al.
NCBI PubMed Central · Papers · License: Open Access
Open Source ↗
Direct PDF ↓
data protection law GDPR
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record
· ID 297288
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.